Madrigal's 15min chart sees MACD Death Cross and KDJ Death Cross.

Madrigal's 15-minute chart exhibited a MACD Death Cross and KDJ Death Cross on September 5, 2025 at 15:15. This suggests that the stock price is poised to decline further, with momentum shifting towards the downside.

Madrigal Pharmaceuticals Inc. (MDGL), a biopharmaceutical company focused on treating fatty liver disease, has experienced significant technical indicator signals that suggest a potential downturn in its stock price. On September 5, 2025, at 15:15, the company's 15-minute chart exhibited a MACD Death Cross and KDJ Death Cross, indicating a potential shift in momentum towards the downside [1].

The MACD (Moving Average Convergence Divergence) Death Cross occurs when the MACD line crosses below the signal line, signaling a bearish trend. The KDJ (Kaufman Adaptive Moving Average) Death Cross, when the K line crosses below the D line, also indicates a bearish trend. These signals suggest that the stock price is poised to decline further, which could be driven by various factors such as market sentiment, earnings reports, or broader economic conditions.

Investors and financial professionals should closely monitor these technical indicators and consider other fundamental factors when making investment decisions. Madrigal Pharmaceuticals has been in the spotlight for its innovative treatments, but the market's focus on these technical signals may influence stock price movements in the short term.

References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_TUA815S9S:0-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4/